Committed players or companies in the field of radiopharmacy are very welcome! If you are interested, you can contact one of our partners or the coordinating office at biosaxony directly. We will be happy to inform you about the possibilities of participating in the network.

nukliD^® bundles unique expertise in the field of radiopharmacy and offers the advantages of a strong network. The cooperation enables:

• Visibility: Partners discuss measures to increase their visibility, such as events or contributions. biosaxony supports or organizes joint appearances, e.g. at (inter)national trade fairs.
• Recruitment, training and further education: Measures to secure, recruit and train skilled workers are jointly identified and coordinated, led by biosaxony.
• Cooperation with public authorities and funding: Development of a position paper to optimize approval processes and generate funding. biosaxony regularly reviews funding opportunities and coordinates coordination with public bodies.
• Technical basis: Coordination to secure radionuclide production and examination of funding opportunities by biosaxony.

This close cooperation creates synergies, promotes innovation and strengthens the location.

There are various ways to support nukliD^® or to cooperate with the network:

1. Membership of the network: Companies or institutions that are active in the field of radiopharmacy can join the network. This opens up opportunities for collaboration, knowledge exchange and joint projects.
2. Research and development: Get actively involved in the development of new radiopharmaceutical solutions by contributing expertise or resources to collaborative projects.
3. Support and sponsorship: Support the network financially or through sponsorship to promote the common goals in cancer research and treatment.
4. Partnership cooperation: Cooperate with one of the network's existing partners or the biosaxony coordinating body to support projects and initiatives.
5. Political and social support: Commit yourself to better framework conditions in nuclear medicine, for example by supporting lobbying work or raising public awareness of the importance of innovative approaches in cancer treatment.

Interested parties can contact biosaxony or one of the network partners directly to discuss specific opportunities for support and collaboration.